Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
:PBH
RESEARCH TOOLSreports
PBH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$64.94 - $90.04
Previous CloseN/A
Volume57.25K
Average Volume (3M)426.84K
Market Cap
$3.65B
Enterprise Value$5.25B
Total Cash (Recent Filing)$97.88M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)17.5
Beta0.36
Next Earnings
Oct 30, 2025EPS Estimate
1.09Last Dividend Ex-Date
Sep 27, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)0.95
Shares Outstanding49,233,437
10 Day Avg. Volume381,459
30 Day Avg. Volume426,836
Financial Highlights & Ratios
PEG Ratio7.62
Price to Book (P/B)2.33
Price to Sales (P/S)3.76
P/FCF Ratio17.56
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue4.61
Enterprise Value/Gross Profit8.28
Enterprise Value/Ebitda14.85
Forecast
1Y Price Target
$85.00Price Target Upside14.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Brand PerformancePrestige is executing its brand building playbook well, resulting in steady organic sales improvement, strong cash generation, and dependable earnings growth.
Debt ManagementStrong free cash flow enabled further debt reduction and share repurchases.
Revenue GrowthFiscal fourth-quarter organic sales were up 7% on broad-based strength, including the women’s health and gastrointestinal categories in the U.S and international.
Bears Say
Guidance And ProjectionsManagement provided initial fiscal 2026 guidance for sales and EPS consistent with consensus.
Market CompetitionThere is room for shares to appreciate with earnings and by narrowing its multiple discount to certain other stable growers in the consumer packaged goods and healthcare space.
Revenue SourcesManagement highlighted strong performance internationally and sequential improvement in Clear Eyes revenues driving stronger-than-expected sales.
Prestige Consumer Healthcare News
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $64.94 and its highest was $90.04 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Prestige Consumer Healthcare’s market cap is $3.65B.
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Oct 30, 2025 which is in 83 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on Aug 07, 2025. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1 by -$0.05.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare pays a Notavailable dividend of $0.475 which represents an annual dividend yield of N/A. See more information on Prestige Consumer Healthcare dividends here
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is 1.09.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,233,437 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $0.95 in its last earnings report, missing expectations of $1. Following the earnings report the stock price went up 6.916%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Currently, no hedge funds are holding shares in PBH
Prestige Consumer Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$85.00 (14.56% Upside)
$85.00 (14.56% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 268.2K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.31%
12-Months-Change
Fundamentals
Return on Equity
12.30%
Trailing 12-Months
Asset Growth
2.94%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc. is a consumer healthcare company engaged in the development, manufacturing, and marketing of over-the-counter (OTC) healthcare products. The company operates primarily in the healthcare sector, focusing on providing effective and accessible self-care solutions. Its core product offerings include a wide range of OTC medications and health-related products, such as pain relievers, digestive products, and eye care items, targeting common health issues among consumers.
PBH Company Deck
PBH Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While the company achieved record fiscal 2025 results, strong international growth, and continued e-commerce expansion, it faced challenges in certain product segments and supply chain issues. The positive financial performance and strategic innovation efforts are tempered by ongoing tariff and inflationary pressures.View all PBH earnings summariesPBH Stock 12 Month Forecast
Average Price Target
$85.00
▲(14.56% Upside)
Technical Analysis
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
1.27% Insiders
44.83% Mutual Funds
2.72% Other Institutional Investors
24.14% Public Companies and
Individual Investors